Final programme | Final Programme - plik PDF, ok. 1 MB

Presentations | PDF files:

1. Implementation of HTA in Ukraine | Presentation - 2,3 MB
   Mykhailo Aristov, Ukraine
2. Challenges for access to pharmaceutical innovation: the WHO perspective | Presentation - 1,6 MB
   Hanne Bak Pedersen, Denmark
3. Management dilemma of hospital care – economical effectiveness or therapeutic effectiveness? How management tools can change reality of inpatient healthcare | Presentation - 900 kB
   Stefan Bogusławski, Poland
4. Safer prescribing: examples of primary care patient safety in the UK | Presentation - 1,2 MB
   Stephen Campbell, UK
5. Management of drug expenditure in PHC and hospitals in the Catalan Institute of Health | Presentation - 2,9 MB
   Eduardo Diogene, Spain
6. Patient involvement in HTA – communicating evidence not emotion. International HTA overview. Next steps for Central and Eastern Europe | Presentation - 1 MB
   Karen Facey, UK
7. Ongoing reforms to manage drug expenditures: impact and implications for the future | Presentation - 1,7 MB
   Brian Godman, UK
8. The roles of HTA agencies: implications for independence and objectivity | Presentation - 150 kB
   Clifford Goodman, USA
9. Tools to manage the introduction of new drugs in Italy: administrative databases, risk-sharing schemes and registries | Presentation - 1,8 MB
   Roberta Joppi, Italy
10. Health care system in Kazakhstan: issues of drug provision and HTA | Presentation - 1,4 MB
    Lyazzat Kosherbaeva, Kazakhstan
11. The impact of health program and health promotion on changing attitudes and community involvement | Presentation - 3,8 MB
    Małgorzata Leźnicka, Poland
12. New model for rational use of medicines at Karolinska University Hospital | Abstract - 50 kB
    Rickard Malmström, Sweden
13. HTA Agency - Polish way to success | Presentation - 5,4 MB
    Wojciech Matusewicz, Poland
14. Obstacles for introducing and realization of public health programmes | Presentation - 2,5 MB
    Rafał Niżankowski, Poland
15. HTA to support local, regional and national level decision-making - experiences from Norway | Presentation - 4,1 MB
    Inger Norderhaug, Norway
16. Private health insurance – mission impossible | Presentation - 1,3 MB
    Adam Pustelnik, Poland
17. Diving the deep sea of evidence: the role of an HTA agency. Example of Germany | Presentation - 1,6 MB
    Alric Rüther, Germany
18. Reforms to better manage expenditure on drugs: impact and implications | Presentation - 2,1 MB
    Ad Schuurman, Nederlands
19. Patients voice in HTA. Experiences of European and Polish patients | Presentation - 1,8 MB
    Tomasz Szelągowski, Poland
20. Health situation and public health - Poland 2013 | Presentation - 1,8 MB
    Mirosław Wysocki, Poland